Helius Medical Technologi... (HSDT)
undefined
undefined%
At close: undefined
0.73
5.84%
After-hours Jan 03, 2025, 04:38 PM EST

Company Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma.

Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.

The company is headquartered in Newtown, Pennsylvania.

Helius Medical Technologies Inc.
Helius Medical Technologies Inc. logo
Country United States
IPO Date Jun 27, 2014
Industry Medical - Devices
Sector Healthcare
Employees 22
CEO Dane Carl Andreeff

Contact Details

Address:
642 Newtown Yardley Road
Newtown, Pennsylvania
United States
Website https://heliusmedical.com

Stock Details

Ticker Symbol HSDT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001610853
CUSIP Number 42328V504
ISIN Number US42328V8019
Employer ID 36-4787690
SIC Code 3845

Key Executives

Name Position
Dane Carl Andreeff President, Chief Executive Officer & Director
Jeffrey S. Mathiesen CPA Chief Financial Officer, Treasurer, Secretary & Director
Dr. Antonella Favit-Van Pelt M.D., Ph.D. Chief Medical Officer
Lawrence Picciano Senior Vice President of Engineering, Quality & Regulatory Affairs

Latest SEC Filings

Date Type Title
Dec 23, 2024 8-K Current Report
Nov 18, 2024 8-K Current Report
Nov 12, 2024 10-Q Quarterly Report
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2024 10-Q Quarterly Report
Aug 12, 2024 8-K Current Report
Aug 09, 2024 8-K Current Report
Jul 24, 2024 S-8 Filing
Jul 05, 2024 4 Filing
Jul 05, 2024 4 Filing